Buyer for a pharmaceutical injectable plant Western Europe

Company to buy

• Industry: Pharmaceuticals
• Subindustry: Manufacturing and Distribution
• Revenue: 2-20 million EUR
• Location: Western Europe
• #CFIE PHB302

Overview of buyer for a pharmaceutical injectable plant in Western Europe

The buyer is a dynamic private pharmaceutical company that began its journey in the early 1990s, transitioning from distribution and importation to establishing its industrial production capabilities. This evolution enabled the company to develop strong partnerships with international suppliers and invest in advanced technologies, allowing for the manufacturing of a diverse range of pharmaceutical forms, including injectables, while maintaining a commitment to quality and innovation. Now they are looking to expand its manufacturing capabilities as part of its strategic growth initiatives. Seeking a medium-sized pharmaceutical manufacturing facility specializing in injectable and possibly oral solid dosages. The ideal target should have an established market presence in Western Europe with capabilities or certifications that adhere to international standards, ensuring the delivery of high-quality pharmaceutical products.

Profile (Strategy) of buyer for a pharmaceutical injectable plant in Western Europe

The buyer is a prominent pharmaceutical group with a significant annual revenue, heavily involved in the production and distribution of generic and biosimilar medications. With a robust foundation in North Africa and Western Europe, the group is pursuing expansion through strategic acquisitions. The focus is on facilities that can enhance their product line, particularly in sterile injectable and solid oral dosages. The buyer values facilities with modern technologies and adherence to the highest standards of product quality and safety.

Activities of suitable targets

The target company should be engaged in the manufacturing of a diverse range of pharmaceutical products, particularly focusing on injectable forms such as ampoules and vials. Additional capabilities in oral solid dosage forms would be advantageous. Also must be holding MAs with existing revenue. The facility should be equipped with the latest technological advancements to maintain efficient production lines and high standards of product quality.

Highlights of buyer for a pharmaceutical injectable plant in Western Europe

• Significant experience and presence in the pharmaceutical sector.
• Operates across multiple regions with a strong focus on Western Europe and North Africa.
• Looking to expand production capabilities with acquisitions.
• Financially robust with a history of substantial revenue figures.
• Committed to maintaining high standards of quality and safety in pharmaceutical manufacturing.

More information on this buyer for a pharmaceutical injectable plant Western Europe

Please get in touch if you are interested in learning more about this buyer for a pharmaceutical injectable plant Western Europe. For more pharma distributors companies for sale please visit the section pharma distributors companies for sale. For other pharma distributors buyers, please visit the section pharma distributors companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.